|
advertisement
|
|
TOP STORIES
Updates on COVID-19 vaccine candidates, FDA policies, company partnerships, and more.
/ read more /
|
| |
|
The Gavi advance market commitment for COVID-19 vaccines is a new financing instrument aimed at incentivizing vaccine manufacturers to produce sufficient and affordable quantities of COVID-19 vaccines.
/ read more /
|
|
| |
ADVERTISEMENT
Featured Resources from BioPharm International
View our online resource center, sponsored by GE Healthcare, to explore a case study and articles on gaining and retaining skilled labor, modular bioprocessing, the good and bad of biosilimiars, and more.
Learn More »  |
| |
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
Industry News
The European Commission has granted marketing authorization to the Janssen Pharmaceutical Companies of Johnson & Johnson for Darzalex (daratumumab) subcutaneous formulation to treat adults with multiple myeloma.
/ read more /
Despite the clear danger of COVID-19 to global health, vaccine opponents have gained ground, as fearful populations lose faith in the capabilities of industry and government to protect public health.
/ read more /
MORE INDUSTRY NEWS
|
| |
ADVERTISEMENT
Innovative Solutions for Protein Analysis and Purification: mAbs and Oligos
An online resource to discover an innovative solution for protein analysis and purification. This site includes useful webcasts, application notes, and more.
Discover now » |
| |
|
|
Biopharma News
The medicine is the first outcome of the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19.
/ read more /
The new vaccine would be made with a Newcastle disease virus vector that expresses the immunogenic spike protein of SARS-CoV-2
/ read more /
More Biopharma News
|
| |
|
Supplier News
CordenPharma announces expansion of lipid excipients supply for coronavirus vaccine scale up.
/ read more /
|
|
Agreements with the PolyPeptide Group and AGC Biologics will scale up production of the Novavax Matrix-M adjuvant.
/ read more /
More Supplier News
|
|
Regulatory News
The protocol on Northern Ireland (NI) once Brexit has been completed has received mixed opinions in industry, according to various press releases.
/ read more /
|
FDA and the US Congress support innovation and access to cheaper medicines.
/ read more /
More Regulatory News
|
|
PRODUCT/SERVICES PROFILE
 |
Catalent Biologics has capabilities and experience in the development, manufacturing, and analytical services for new biological entities, cell and gene therapies, biosimilars, and antibody-drug conjugates.
/ read more /
|
|
|
|
eBook
|
The Pharmacopoeia Compliance Series features a description of ways biopharma companies can participate in monograph development, a case study of a practical approach to pharmacopoeial compliance, and a summary of this 12-part series.
|
|
|
|
| |
